Journal article

Phosphoserine-modified calcium phosphate cements: bioresorption and substitution


Authors listOffer, Liliana; Veigel, Bastian; Pavlidis, Theodoros; Heiss, Christian; Gelinsky, Michael; Reinstorf, Antje; Wenisch, Sabine; Lips, Katrin Susanne; Schnettler, Reinhard

Publication year2011

Pages11-19

JournalJournal of Tissue Engineering and Regenerative Medicine

Volume number5

Issue number1

ISSN1932-6254

eISSN1932-7005

Open access statusGold

DOI Linkhttps://doi.org/10.1002/term.283

PublisherWiley


Abstract
This work reports the effects of phosphoserine addition on the biodegradability of calcium phosphate cements. The characteristics of a phosphoserine-modified calcium phosphate cement without collagen in a large animal model are presented here for the first time. Critical size bone defects in the proximal tibia of 10 sheep were filled with the bone cement, and five sheep with empty defects were included as controls. The sheep were sacrificed after either 10 days or 12 weeks, and bones were processed for histological, histomorphometric and enzyme histochemical analyses as well as transmission electron microscopic examination. After 12 weeks, there was no significant reduction in either the implant or the bone defect cross-sectional area. Different amounts of fibrous tissue were observed around the implant and in the bone defect after 12 weeks. The direct bone-implant contact decreased after 12 weeks (p = 0.034). Although the implanted material properly filled the defect and promoted an initial activation of macrophages and osteoblasts, the resorption and simultaneous substitution did not reach expected levels during the experimental time course. Although other studies have shown that the addition of phosphoserine to calcium phosphate cements that have already been modified with collagen I resulted in an acceleration of cement resorption and bone regeneration, this study demonstrates that phosphoserine-modified calcium phosphate cements without collagen perform poorly in the treatment of bone defects. Efforts to use phosphoserine in the development of new composites should take into consideration the need to improve osteoconduction simultaneously via other means. Copyright (C) 2010 John Wiley & Sons, Ltd.



Citation Styles

Harvard Citation styleOffer, L., Veigel, B., Pavlidis, T., Heiss, C., Gelinsky, M., Reinstorf, A., et al. (2011) Phosphoserine-modified calcium phosphate cements: bioresorption and substitution, Journal of Tissue Engineering and Regenerative Medicine, 5(1), pp. 11-19. https://doi.org/10.1002/term.283

APA Citation styleOffer, L., Veigel, B., Pavlidis, T., Heiss, C., Gelinsky, M., Reinstorf, A., Wenisch, S., Lips, K., & Schnettler, R. (2011). Phosphoserine-modified calcium phosphate cements: bioresorption and substitution. Journal of Tissue Engineering and Regenerative Medicine. 5(1), 11-19. https://doi.org/10.1002/term.283



Keywords


bioresorptionBONE-CEMENTcalcium phosphate cementsCARBONATEfibrous tissueforeign body giant cellL-SERINEOSTEOBLASTosteoclastOSTEOPONTINphosphoserineRESORPTION

Last updated on 2025-18-06 at 13:48